| scholarly article | Q13442814 |
| P2093 | author name string | Timothy S Kern | |
| Bendi Gong | |||
| Denise A Hatala | |||
| Ling Zheng | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | retinal ischemia | Q18554330 |
| P304 | page(s) | 361-367 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Investigative Ophthalmology Visual Science | Q6060707 |
| P1476 | title | Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. | |
| P478 | volume | 48 |
| Q59796439 | A Contrast in Pathogenic Responses between C57BL/6J and BALB/cJ Mice Using a Model of Retinal Injury |
| Q55661819 | A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure. |
| Q47803336 | A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model |
| Q37773118 | A review of string vessels or collapsed, empty basement membrane tubes |
| Q37719402 | Abnormal levels of histone methylation in the retinas of diabetic rats are reversed by minocycline treatment |
| Q31028167 | Activation of autophagy in a rat model of retinal ischemia following high intraocular pressure |
| Q41815883 | Activation of the Nrf2/HO-1 antioxidant pathway contributes to the protective effects of Lycium barbarum polysaccharides in the rodent retina after ischemia-reperfusion-induced damage |
| Q58698678 | Arginase 1 promotes retinal neurovascular protection from ischemia through suppression of macrophage inflammatory responses |
| Q37603245 | Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury |
| Q35221390 | Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells |
| Q47294877 | Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats |
| Q90311517 | Cellular Mechanisms of Angiogenesis in Neonatal Rat Models of Retinal Neurodegeneration |
| Q51040455 | Conditional Deletion of Bmal1 Accentuates Microvascular and Macrovascular Injury. |
| Q38189165 | Connexin hemichannel induced vascular leak suggests a new paradigm for cancer therapy |
| Q48654177 | Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia |
| Q47770967 | Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications |
| Q28476485 | Curcumin inhibits neuronal and vascular degeneration in retina after ischemia and reperfusion injury |
| Q36015795 | Decrease in retinal neuronal cells in streptozotocin-induced diabetic mice. |
| Q41506713 | Degeneration of retinal ganglion cells in diabetic dogs and mice: relationship to glycemic control and retinal capillary degeneration |
| Q41293250 | Delayed axonal degeneration in slow Wallerian degeneration mutant mice detected using diffusion tensor imaging |
| Q37635278 | Deletion of thioredoxin-interacting protein preserves retinal neuronal function by preventing inflammation and vascular injury |
| Q37130174 | Delivery of antioxidant enzyme genes to protect against ischemia/reperfusion-induced injury to retinal microvasculature. |
| Q53128283 | Does autoimmunity of endogenous vasoactive neuropeptides cause retinopathy in humans? |
| Q37309486 | Dual Anti-Inflammatory and Anti-Angiogenic Action of miR-15a in Diabetic Retinopathy. |
| Q60312810 | Echinacoside protects retinal ganglion cells from ischemia/reperfusion-induced injury in the rat retina |
| Q54031031 | Effect of aminoguanidine on sciatic functional index, oxidative stress, and rate of apoptosis in an experimental rat model of ischemia-reperfusion injury. |
| Q41775336 | Electroporation-mediated gene delivery of cleavage-resistant pro-nerve growth factor causes retinal neuro- and vascular degeneration. |
| Q57537747 | Electroretinography in streptozotocin diabetic rats following acute intraocular pressure elevation |
| Q24656049 | Endocannabinoids in the retina: from marijuana to neuroprotection |
| Q37860958 | Endothelin-1 role in human eye: a review |
| Q35041129 | Enhancing the function of CD34(+) cells by targeting plasminogen activator inhibitor-1 |
| Q34603008 | Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina |
| Q55692320 | Fewer Functional Deficits and Reduced Cell Death after Ranibizumab Treatment in a Retinal Ischemia Model. |
| Q64263839 | From Ganglion Cell to Photoreceptor Layer: Timeline of Deterioration in a Rat Ischemia/Reperfusion Model |
| Q52367727 | Gene expression in retinal ischemic post-conditioning. |
| Q37154210 | Generation of functional hemangioblasts from human embryonic stem cells. |
| Q101403075 | Global assessment of arteriolar, venular and capillary changes in normal tension glaucoma |
| Q48249626 | Human bone marrow mesenchymal stem cells for retinal vascular injury |
| Q37667292 | Hypoxia-Inducible Factor-1α Target Genes Contribute to Retinal Neuroprotection |
| Q37236104 | Hypoxia-ischemia and retinal ganglion cell damage |
| Q37126430 | Hypoxic-Preconditioned Bone Marrow Stem Cell Medium Significantly Improves Outcome After Retinal Ischemia in Rats |
| Q42556810 | Identification of primary retinal cells and ex vivo detection of proinflammatory molecules using flow cytometry |
| Q35535755 | Identification of protein network alterations upon retinal ischemia-reperfusion injury by quantitative proteomics using a Rattus norvegicus model |
| Q33509427 | Imaging of long-term retinal damage after resolved cotton wool spots |
| Q39155136 | Integrative analysis of ocular complications in atherosclerosis unveils pathway convergence and crosstalk. |
| Q35928454 | Interleukin-1β and mitochondria damage, and the development of diabetic retinopathy |
| Q94603123 | Involvement of moesin phosphorylation in ischemia/reperfusion induced inner blood-retinal barrier dysfunction |
| Q89598307 | Is the Arginase Pathway a Novel Therapeutic Avenue for Diabetic Retinopathy? |
| Q36707429 | Is the peripapillary retinal perfusion related to myopia in healthy eyes? A prospective comparative study. |
| Q42415885 | Ischemia-reperfusion injury induces occludin phosphorylation/ubiquitination and retinal vascular permeability in a VEGFR-2-dependent manner |
| Q37101882 | Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells |
| Q35795518 | JNK Inhibition Reduced Retinal Ganglion Cell Death after Ischemia/Reperfusion In Vivo and after Hypoxia In Vitro |
| Q37710907 | KUS121, a VCP modulator, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress |
| Q36410637 | Liver X receptor modulates diabetic retinopathy outcome in a mouse model of streptozotocin-induced diabetes |
| Q35865475 | Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury |
| Q38115815 | MRI biomarkers for evaluation of treatment efficacy in preclinical diabetic retinopathy. |
| Q37734597 | Metal chelator combined with permeability enhancer ameliorates oxidative stress-associated neurodegeneration in rat eyes with elevated intraocular pressure |
| Q84475030 | Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo |
| Q42701874 | Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury |
| Q92823163 | Modulating Expression of Thioredoxin Interacting Protein (TXNIP) Prevents Secondary Damage and Preserves Visual Function in a Mouse Model of Ischemia/Reperfusion |
| Q41667375 | Modulation of valosin-containing protein by Kyoto University Substances (KUS) as a novel therapeutic strategy for ischemic neuronal diseases |
| Q58728022 | Multimodal imaging in acute retinal ischemia: spectral domain OCT, OCT-angiography and fundus autofluorescence |
| Q35522186 | Neuroprotection from retinal ischemia/reperfusion injury by NOX2 NADPH oxidase deletion |
| Q36463921 | Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury |
| Q61800528 | Neuroprotective effects of PPARα in retinopathy of type 1 diabetes |
| Q42470643 | Neurovascular protective effect of FeTPPs in N-methyl-D-aspartate model: similarities to diabetes |
| Q35027733 | Noninvasive topical loading for manganese-enhanced MRI of the mouse visual system |
| Q37719154 | Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury |
| Q47100531 | PPARα is essential for retinal lipid metabolism and neuronal survival. |
| Q38713219 | Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPARα. |
| Q42591699 | Pharmacologic intervention targeting glycolytic-related pathways protects against retinal injury due to ischemia and reperfusion |
| Q47361893 | Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration. |
| Q47119067 | Post-ischemic treatment with azithromycin protects ganglion cells against retinal ischemia/reperfusion injury in the rat. |
| Q46079353 | Potential prophylactic role of aminoguanidine in diabetic retinopathy and nephropathy in experimental animals |
| Q36964484 | Progressive morphological changes and impaired retinal function associated with temporal regulation of gene expression after retinal ischemia/reperfusion injury in mice |
| Q34456143 | Protection of retinal ganglion cells and retinal vasculature by Lycium barbarum polysaccharides in a mouse model of acute ocular hypertension |
| Q36904161 | Protective Effect of a GLP-1 Analog on Ischemia-Reperfusion Induced Blood-Retinal Barrier Breakdown and Inflammation |
| Q33943655 | Protective and antioxidant effects of PPARα in the ischemic retina |
| Q84958672 | Protective effects of the β3-adrenoceptor agonist CL316243 against N-methyl-D-aspartate-induced retinal neurotoxicity |
| Q38430298 | RORα modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis |
| Q58700287 | Rapamycin and fasting sustain autophagy response activated by ischemia/reperfusion injury and promote retinal ganglion cell survival |
| Q52560208 | Reduction of Endoplasmic Reticulum Stress Improves Angiogenic Progenitor Cell function in a Mouse Model of Type 1 Diabetes. |
| Q43064763 | Reduction of inducible nitric oxide synthase via angiotensin receptor blocker prevents the oxidative retinal damage in diabetic hypertensive rats |
| Q50630590 | Regression of retinal capillaries following N-methyl-D-aspartate-induced neurotoxicity in the neonatal rat retina. |
| Q24647760 | Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory |
| Q33930338 | Resveratrol inhibits neuronal apoptosis and elevated Ca2+/calmodulin-dependent protein kinase II activity in diabetic mouse retina |
| Q34141722 | Retinal Hemorrhage in Abusive Head Trauma |
| Q35056863 | Retinal blood flow in glaucomatous eyes with single-hemifield damage |
| Q89220467 | Retinal ganglion cell complex and peripapillary retinal nerve fiber layer thicknesses following carotid endarterectomy |
| Q28564803 | Retinal ganglion cell death is induced by microglia derived pro-inflammatory cytokines in the hypoxic neonatal retina |
| Q37122850 | Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes |
| Q48245382 | Retinal vascular injuries and intravitreal human embryonic stem cell-derived haemangioblasts |
| Q36065113 | Retinylamine Benefits Early Diabetic Retinopathy in Mice |
| Q41124896 | Silencing p75(NTR) prevents proNGF-induced endothelial cell death and development of acellular capillaries in rat retina |
| Q90134174 | Spaceflight influences gene expression, photoreceptor integrity, and oxidative stress-related damage in the murine retina |
| Q35877208 | Systemic and Intravitreal Delivery of Dendrimers to Activated Microglia/Macrophage in Ischemia/Reperfusion Mouse Retina |
| Q51662239 | TOWARDS A TREATMENT FOR DIABETIC RETINOPATHY: Intravitreal Toxicity and Preclinical Safety Evaluation of Inducible Nitric Oxide Synthase Inhibitors. |
| Q89879885 | Targeting Neurovascular Interaction in Retinal Disorders |
| Q58769421 | The Alternative Complement System Mediates Cell Death in Retinal Ischemia Reperfusion Injury |
| Q92538952 | The CD40-ATP-P2X 7 Receptor Pathway: Cell to Cell Cross-Talk to Promote Inflammation and Programmed Cell Death of Endothelial Cells |
| Q35145146 | The distribution of Mn2+ in rabbit eyes after topical administration for manganese-enhanced MRI. |
| Q55395409 | The effects of bevacizumab treatment in a rat model of retinal ischemia and perfusion injury. |
| Q30495106 | The mouse retina as an angiogenesis model |
| Q47913676 | The protective effects of dexmedetomidine against apoptosis in retinal ischemia/reperfusion injury in rats |
| Q34731408 | The protective effects of the proteasome inhibitor bortezomib (velcade) on ischemia-reperfusion injury in the rat retina |
| Q35180049 | The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models |
| Q38387172 | Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity. |
| Q34109774 | Time-dependent Gene Profiling Indicates the Presence of Different Phases for Ischemia/Reperfusion Injury in Retina |
| Q34024355 | Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions |
| Q47387315 | Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage |
| Q46921468 | Upregulated endothelin system in diabetic vascular dysfunction and early retinopathy is reversed by CPU0213 and total triterpene acids from Fructus Corni |
| Q89704566 | VEGFD Protects Retinal Ganglion Cells and, consequently, Capillaries against Excitotoxic Injury |
| Q64251077 | Vagal Nerve Stimulation Attenuates Ischemia-Reperfusion Induced Retina Dysfunction in Acute Ocular Hypertension |
| Q28655924 | Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature |
| Q90090997 | Vascular progenitors generated from tankyrase inhibitor-regulated naïve diabetic human iPSC potentiate efficient revascularization of ischemic retina |
| Q27028225 | Vitreous mediators in retinal hypoxic diseases |
| Q36145965 | p38 mitogen-activated protein kinase-induced nuclear factor kappa-light-chain-enhancer of activated B cell activity is required for neuroprotection in retinal ischemia/reperfusion injury |
Search more.